Noxopharm clinical trial reveals anti-inflammatory response in COVID-19 patients
25 Aug 2021 //
BUSINESSWIRE
Noxopharm Reports Idronoxil Achieves Major Industry Goal of Converting ‘Cold’
23 Jul 2020 //
PRESS RELEASE
BRIEF-Noxopharm Says U.S. FDA Grants IND Approval To Veyonda
21 Feb 2020 //
FINNEWSNETWORK